This report was first published by Endpoints News. To see the original version, click here
For the first time in four years, Endpoints News is raising the bar for what it means to be a top-paid CEO.
The previous floor of $20 million is no longer rich enough. The biopharma world’s new minimum is now an annual pay package of $25 million. Endpoints analyzed paydays for 448 CEOs of public life sciences companies worth more than $100 million, kicking off a weeklong slate of stories that comprise our annual industry pay report.
您已阅读2%（525字），剩余98%（22594字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。